PubRank

Elisabeth Schwarz

Author PubWeight™ 45.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004 5.62
2 Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002 2.09
3 Stimulation of poly(A) polymerase through a direct interaction with the nuclear poly(A) binding protein allosterically regulated by RNA. EMBO J 2003 1.55
4 p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer 2010 1.34
5 Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 2005 1.22
6 Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas. PLoS One 2013 1.19
7 Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 2008 1.09
8 Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 2005 0.99
9 Proneurotrophin-3 may induce Sortilin-dependent death in inner ear neurons. Eur J Neurosci 2011 0.97
10 Intrinsic structural disorder of mouse proNGF. Proteins 2009 0.96
11 Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation. Protein Sci 2003 0.95
12 Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting. BMC Cancer 2009 0.92
13 Smad4 deficiency in cervical carcinoma cells. Oncogene 2005 0.91
14 Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy. EMBO Mol Med 2011 0.91
15 Structural and dynamical characterization of fibrils from a disease-associated alanine expansion domain using proteolysis and solid-state NMR spectroscopy. J Am Chem Soc 2008 0.91
16 Human papillomaviruses in lymph node neck metastases of head and neck cancers. Acta Otolaryngol 2005 0.89
17 Biophysical comparison of BMP-2, ProBMP-2, and the free pro-peptide reveals stabilization of the pro-peptide by the mature growth factor. J Biol Chem 2005 0.88
18 Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension. Biochemistry 2008 0.87
19 Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms. Cancer Lett 2005 0.86
20 The mature part of proNGF induces the structure of its pro-peptide. FEBS Lett 2004 0.85
21 The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding. FEBS J 2009 0.85
22 SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV. Int J Cancer 2010 0.84
23 The pro-peptide of proNGF: structure formation and intramolecular association with NGF. Protein Sci 2007 0.84
24 The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres. J Control Release 2010 0.83
25 Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas. Oral Oncol 2004 0.83
26 A folded and functional protein domain in an amyloid-like fibril. Protein Sci 2008 0.82
27 HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers. Anticancer Res 2006 0.82
28 Effect of oculopharyngeal muscular dystrophy-associated extension of seven alanines on the fibrillation properties of the N-terminal domain of PABPN1. FEBS J 2007 0.82
29 Polyalanine-independent conformational conversion of nuclear poly(A)-binding protein 1 (PABPN1). J Biol Chem 2012 0.82
30 Oxidative folding of nerve growth factor can be mediated by the pro-peptide of neurotrophin-3. FEBS Lett 2007 0.81
31 The non-ionic detergent Brij 58P mimics chaperone effects. FEBS Lett 2002 0.80
32 Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice. Shock 2013 0.80
33 Identification of a core domain within the proregion of bone morphogenetic proteins that interacts with the dimeric, mature domain. Biochem Biophys Res Commun 2011 0.80
34 Monitoring fibril formation of the N-terminal domain of PABPN1 carrying an alanine repeat by tryptophan fluorescence and real-time NMR. FEBS Lett 2008 0.79
35 High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition. BMC Cancer 2007 0.79
36 The unresolved puzzle why alanine extensions cause disease. Biol Chem 2013 0.79
37 The pro-form of BMP-2 exhibits a delayed and reduced activity when compared to mature BMP-2. Growth Factors 2011 0.78
38 Biophysical and structural characterization of a folded core domain within the proregion of growth and differentiation factor-5. FEBS J 2014 0.78
39 Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cells. J Biol Chem 2004 0.78
40 Influence of the stability of a fused protein and its distance to the amyloidogenic segment on fibril formation. PLoS One 2010 0.78
41 Examination of the slow unfolding of pro-nerve growth factor argues against a loop threading mechanism for nerve growth factor. Biochemistry 2006 0.77
42 Different morphology of amyloid fibrils originating from agitated and non-agitated conditions. Amyloid 2013 0.77
43 A core domain of the BMP2 proregion is sufficient for the biogenesis of mature homodimeric growth factor. Biol Chem 2015 0.76
44 Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency. J Inherit Metab Dis 2013 0.76
45 The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2). J Biol Chem 2013 0.75
46 Real-time duplex PCR for simultaneous HPV 16 and HPV 18 DNA quantitation. J Virol Methods 2013 0.75
47 Influence of the polypeptide environment next to amyloidogenic peptides on fibril formation. Biol Chem 2014 0.75